Accueil>>Signaling Pathways>> PROTAC>> Target Protein Ligand-Linker Conjugate>>K-Ras ligand-Linker Conjugate 3

K-Ras ligand-Linker Conjugate 3

Catalog No.GC39190

K-Ras ligand-Linker Conjugate 3 (composé 001371) incorpore un ligand pour la fraction de recrutement de K-Ras et un lieur PROTAC, qui recrutent des ligases E3 (telles que VHL, CRBN, MDM2 et IAP). Le conjugué ligand K-Ras-Linker 3 peut être utilisé dans la synthèse de PROTAC K-Ras Degrader-1, qui est un puissant dégradeur PROTAC K-Ras qui présente une efficacité de dégradation ≥ 70 % dans les cellules SW1573.

Products are for research use only. Not for human use. We do not sell to patients.

K-Ras ligand-Linker Conjugate 3 Chemical Structure

Cas No.: 2378261-87-9

Taille Prix Stock Qté
1mg
510,00 $US
En stock
5mg
1 530,00 $US
En stock
10mg
2 364,00 $US
En stock
50mg Please Inquire Please Inquire
100mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

K-Ras ligand-Linker Conjugate 3 (Compound 001371) incorporates a ligand for FAK (a KRas recruiting moiety), and a PROTAC linker, which recruit E3 ligases (such as VHL, CRBN, MDM2, and IAP). K-Ras ligand-Linker Conjugate 3 can be extensively used for PROTAC-mediated protein degradation[1].

[1]. Andrew P. Crew, et al. Modulators of proteolysis and associated methods of use. WO2019195609A2.

Avis

Review for K-Ras ligand-Linker Conjugate 3

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for K-Ras ligand-Linker Conjugate 3

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.